USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Euroimmun Medizinische Labordiagnostika AG

USPTO PatentsView assignee record - 71 granted patents across 28 technology areas, recorded in grant years 2016–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties).

RSS updates for this company

The verdict

According to USPTO PatentsView, Euroimmun ranks #4,876 of 49,997 tracked US assignees by granted-patent volume, with 71 patents across 28 technology areas.

#4,876
of 49,997 US assignees by volume
Top 24%
by Innovation Score (45.1/100)
10.9
avg claims per patent
+250%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R4876 · Foreign Corporation #4,876 · 71 grants

GRANTS-SMALL · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-PAR · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

  • GRANTS-SMALL 71 grants
  • TOP-DECILE #4,876/49,997
  • PHOTO-FINISH Clarius Mobile Health
  • CPC-FOCUS G01N · 28 areas
  • INNOV-PAR 45.1/100
  • CLAIMS-PAR 10.9 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • VEL-SURGE +250% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Clarius Mobile Health Corp. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Innovation-score neighbourhood around Euroimmun

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Euroimmun's Innovation Score is 45.1/100 (top 24% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Where Euroimmun's grants concentrate

Euroimmun Medizinische Labordiagnostika AG is a focused PatentsView assignee: 28 CPC subclasses with 64.8% of grants classified under G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties). Peak complete grant year is 2020 (16 grants) versus a trough of 1 in 2016. By volume, Euroimmun sits between Clarius Mobile Health Corp. and Guangdong Aoyun Technology Co., Ltd..

Euroimmun's three-year grant acceleration

From 2019–2021 to 2022–2024, Euroimmun Medizinische Labordiagnostika AG moved from 30 to 23 grants (0.77x the prior three-year total, a multiple, not a CAGR). See the growth leaderboard.

Who files at Euroimmun's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Euroimmun holds 71 patents at rank #4,876, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Euroimmun

By rank, the assignees closest to #4,876 in granted patent volume.

Leaders in G01N (Investigating OR Analysing Materials BY Determining Their…)

Other assignees with the most granted patents in Euroimmun's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Euroimmun, neither rank-band nor same-CPC leaders (those blocks stay above).

Similar innovation score

Nearest assignees by Innovation Score (45 here).

Similar claim depth

Nearest assignees by average claims per patent (10.9 here).

Euroimmun's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

45 Top 24% higher than 76% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

05101520 201620182019202020212022202320242025 8
USPTO utility patent grants by year · 2016–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table
Euroimmun Medizinische Labordiagnostika AG patent grants by year, 2015–2025
Year Patents Granted Share of Period
2016 1 1.4%
2018 9 12.7%
2019 4 5.6%
2020 16 22.5%
2021 10 14.1%
2022 9 12.7%
2023 8 11.3%
2024 6 8.5%
2025partial year 8 11.3%

Where it ranks

Overall rank by patents

#4,876

of 49,997 tracked assignees

Innovation Score

45.1 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Euroimmun Medizinische Labordiagnostika AG's patent record in context - here's where to go next.

  • Euroimmun Medizinische Labordiagnostika AG's lead technology class is G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties), 64.8% of its portfolio - see every assignee active in that class. Explore G01N
  • Ranked #4,876 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Euroimmun Medizinische Labordiagnostika AG against Clarius Mobile Health Corp., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 45.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.